Value 40%
How cheap is HALO compared to other Healthcare stocks? Lower forward P/E, EV/EBITDA, and P/FCF earn higher Value scores.
72.6
- Forward P/E
- 8.39
- EV / EBITDA
- 8.77
- P / FCF
- 12.51
- PEG
- n/m
HALO Halozyme Therapeutics, Inc.
69.8
Opportunity
Raw BEACON composite
How to read this page
The big number above is HALO's BEACON composite — a 0-100 sector-relative score blending three factors: Value (40%), Quality (35%), and Momentum (25%). A score of 70+ means HALO ranks well against its Healthcare peers on most factors. The current macro regime is then overlaid to produce the regime-adjusted score lower on this page.
Every metric on this page is computed against Healthcare peers, not the whole market. A "cheap" P/E in tech isn't the same as a "cheap" P/E in utilities. Read the full methodology →
Quality 35%
How healthy is the underlying business? Higher gross margin, ROE, and FCF yield (and lower debt) earn higher Quality scores.
88.2
- Gross Margin
- +78.1%
- ROE
- +649.2%
- Debt / Equity
- 0.00
- FCF Yield
- +7.99%
Momentum 25%
Is the market starting to recognize the value? Above the 200-day moving average and a positive 3-month return earn higher Momentum scores.
39.7
- Price
- $67.08
- 200-day SMA
- $67.36
- vs 200-day
- -0.4%
- 3-month change
- -7.4%
HALO vs Healthcare Median
Each row compares HALO to the median stock in the Healthcare sector. ▲ Better means HALO is better positioned than the sector median for that metric (cheaper for valuation metrics, healthier for quality metrics). ▼ Worse means the opposite. Tiny differences (within 2%) are shown as In line.
| Metric | HALO | Healthcare Median | vs Median |
|---|---|---|---|
| Forward P/E | 8.39 | 11.87 | ▲ Better |
| EV / EBITDA | 8.77 | 9.00 | ▲ Better |
| P / FCF | 12.51 | 10.33 | ▼ Worse |
| PEG Ratio | n/m | 0.09 | ▼ n/m |
| Gross Margin | +78.1% | +64.2% | ▲ Better |
| ROE | +649.2% | -6.6% | ▲ Better |
| Debt / Equity | 0.00 | 0.27 | ▲ Better |
| FCF Yield | +8.0% | +0.9% | ▲ Better |
Regime Fit
The current macro regime favors some sectors and pressures others. BEACON multiplies HALO's raw score by a sector-specific multiplier to produce its regime-adjusted score. The regime contribution below is how many score points the overlay added (or subtracted) for this stock.
Current regimeEXPANSION
Confidence70.0%
Fit► Neutral
Base multiplier1.00x
Effective multiplier1.00x
Regime contribution0.0 pts
Raw BEACON69.8
Regime-adjusted69.8
Global rank#39
Sector rank#5 / 150
Financial Health
These five indicators drive BEACON's hard red-flag gates. If any of them lands in the red zone, the composite score is capped at 40 regardless of how the Value/Quality/Momentum sub-scores look. Refreshed weekly from HALO's most recent annual filings.
Altman Z-Score
3.91
Safe Zone
≥ 3.0 safe · 1.81-2.99 grey · < 1.8 distress
Current Ratio
4.66
Healthy
≥ 1.5 healthy · 1.0-1.49 adequate · < 0.5 critical
Revenue YoY Growth
+37.6%
Growing
≥ +5% growing · 0 to -15% declining · < -15% sharp
Consecutive Negative FCF Years
0
None
3+ years triggers a red flag
Consecutive Revenue Decline Years
0
None
2+ years (combined w/ -15% YoY) triggers a red flag
Interested in gold & mining?
GoldStockData rates 850+ precious metals miners on 11 quantitative signal layers.
Visit GoldStockData →